[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540260":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":59,"collaborators":61,"id":64,"slug":10,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":10,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Bioray Laboratories","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"BRL-101",null,"All patients who have received BRL-101",[13],"Other: Assessments",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","Assessments","Safety and efficacy assessments",[9],[21],{"name":22,"affiliation":5,"role":23},"Xiaochen Wang, PhD","STUDY_CHAIR",[25],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","021-64340008","xcwang@brlmed.com",[30,46],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army","RECRUITING","Nanning","Guangxi","530021","China",{"type":38,"coordinates":39},"Point",[40,41],108.31667,22.81667,{"lat":41,"lon":40},[44],{"name":45,"role":26,"phone":10,"phoneExt":10,"email":10},"Xinhua Zhang, PhD",{"facility":47,"status":32,"city":48,"state":49,"zip":50,"country":36,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"Xiangya Hospital of Central South University","Changsha","Hunan","510510",{"type":38,"coordinates":52},[53,54],112.97087,28.19874,{"lat":54,"lon":53},[57],{"name":58,"role":26,"phone":10,"phoneExt":10,"email":10},"Bin Fu, PhD",{"type":60,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[62,63],{"name":31,"class":16},{"name":47,"class":16},"100540260",false,"NCT06314529","Long-term Follow-up Study of BHC001 for TDT","Long-term Follow-up Study of BHC001 in the Treatment of Transfusion-dependent β-thalassemia","Inclusion Criteria:\n\n1. Provision of written informed consent for this study by subjects, or as applicable, subject's parent(s)\u002Flegal guardian(s)\n2. Treated with BRL-101 for therapy of transfusion-dependent β-thalassemia.\n\nExclusion Criteria:\n\n\\- There are no exclusion criteria for this study","ALL","5 Years","35 Years",{"count":74,"type":75},6,"ESTIMATED","OBSERVATIONAL","Observe long-term safety risk and long-term efficacy after intravenous infusion of BHC001 in TDT subjects.",[79],"Thalassemia, Beta","2024-03-11",{"date":82,"type":83},"2024-03-18","ACTUAL",{"date":85,"type":83},"2022-12-14",{"date":87,"type":75},"2037-05-10",{"name":5,"class":6},2]